Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hickling

Showing results (91-100 of 92) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 92 results.
Mabs|September 3, 2013
CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous deliveryBrian J Fennell, Barry McDonnell, Amy Sze Pui Tam, et al.
Plos Medicine|October 30, 2020
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortiumSigne Hässler, Delphine Bachelet, Julianne Duhaze, et al.
Pageof 10

Showing results (91-100 of 92) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 92 results.
Mabs|September 3, 2013
CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous deliveryBrian J Fennell, Barry McDonnell, Amy Sze Pui Tam, et al.
Plos Medicine|October 30, 2020
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortiumSigne Hässler, Delphine Bachelet, Julianne Duhaze, et al.
Pageof 10